Rich consumers taking GLP-1s are rebuying their wardrobes and eating smaller, fancier dishes—it’s a factor saving the luxury sector right now

Luxury sales have softened slightly amid geopolitical strain, but tech (AI) and new trends are reshaping demand.
Weight‑loss drugs like Ozempic/Mounjaro are sparking a “new wardrobe” and YOLO spending vibe—plus smaller, higher‑quality dining choices.
The sector still struggles with size and price inclusivity, creating an opening for brands that broaden sizing and offer more accessible luxury.